Article
The Emerging Potential for Network Analysis to Inform Precision Cancer Medicine
14 Jun 2018
Abstract excerpt
Precision cancer medicine promises to tailor clinical decisions to patients using genomic information. Indeed, successes of drugs targeting genetic alterations in tumors, such as imatinib that targets BCR-ABL in chronic myelogenous leukemia, have demonstrated the power of this approach. However, biological systems are complex, and patients may differ not only by the specific genetic alterations in their tumor,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
